Repligen's total assets for Q2 2024 were $2.86B, an increase of 0.44% from the previous quarter. RGEN total liabilities were $875.56M for the fiscal quarter, a -0.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.